AI assistant
Sending…
CRYO CELL INTERNATIONAL INC — Director's Dealing 2021
Aug 26, 2021
34715_dirs_2021-08-26_0cde0ea2-7f1b-4b46-89df-2f2004456c38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYO CELL INTERNATIONAL INC (CCEL)
CIK: 0000862692
Period of Report: 2021-08-24
Reporting Person: Portnoy Mark L. (Director, Co-CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-24 | Common Stock | M | 67816 | $2.90 | Acquired | 787514 | Direct |
| 2021-08-24 | Common Stock | F | 25500 | $10.50 | Disposed | 762014 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-24 | Stock Option | $2.90 | M | 67816 | Disposed | 2021-08-31 | Common Stock (67816) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 42266 | Indirect |
| Common Stock | 71529 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $3.14 | 2026-04-15 | Common Stock (59459) | 59459 | Direct |
| Stock Option | $7.92 | 2028-03-08 | Common Stock (20000) | 20000 | Direct |
| Stock Option | $7.53 | 2029-08-30 | Common Stock (22222) | 22222 | Direct |
| Stock Option | $7.28 | 2029-12-20 | Common Stock (20000) | 20000 | Direct |
Footnotes
F1: Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
F2: Shares of common stock were withheld by the Company as payment for the exercise price of the common stock and associated tax liabilities.
F3: Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
More from CRYO CELL INTERNATIONAL INC
Regulatory Filings
2026
May 8
Interim / Quarterly Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 12
Annual Report
2026
Feb 27
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Nov 24